|Company Name||iRhythm Technologies, Inc.|
|Class Period||August 4, 2020 to January 28, 2021|
|Motion Deadline||April 2, 2021|
The Thornton Law Firm announces that a class action lawsuit has been filed on behalf of investors of iRhythm Technologies, Inc. (NASDAQ: IRTC). The case is currently in the lead plaintiff stage. Investors who purchased IRTC stock or other securities between August 4, 2020 and January 28, 2021 may contact the Thornton Law Firm’s investor protection team by submitting their information above. Investors may also email firstname.lastname@example.org or call 617-531-3917.
The complaint alleges that iRhythm and its senior executive made misleading statements to investors and failed to disclose that: (1) iRhythm’s business would suffer as a result of the CMS’s rulemaking; (2) reimbursement rates would in fact plummet; and (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in iRhythm’s business.
Interested iRhythm investors have until April 2, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. Investors do not need to be a lead plaintiff in order to be a class member. A lead plaintiff acts on behalf of all other investor class members in managing the class action. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney.
Thornton Law Firm’s securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.